Cervu: University spinoff seeking to reduce chronic pelvic pain and painful sex for females.

1

OBGYN working to improve care for his patients teamed with experienced industrial designer to develop treatment.

2

10% of women suffer from chronic pelvic pain and dyspareunia (pain with intercourse).

3

Female cancer survivors are disproportionately affected, with 50% of 15 million survivors in the US and EU affected.

4

100+ hours of interviews of patients and providers who would use the technology

5

Provisional patent filed; owned jointly and institutionally supported by NCSU and UNC for exclusive licensing to Cervu

6

D2C non-regulated path to market, with later option to seek FDA clearance and obtain insurance coverage

As an OBGYN and spouse of a physical therapist, Dr. Rosenbaum sees a lot of patients affected by these conditions, and can empathize with the physical, social, and economic suffering they experience as they seek treatment. Paired with Ms. Scheer, Cervu has matured to develop a therapy product that excites patients and physical therapists alike.

Cervu

University spinoff seeking to reduce chronic pelvic pain and painful sex for females

Highlights

Our Team

Pitch